Istemrewind

Operating under the name GenLife Biotech, Istemrewind is a medical device company focused on the regenerative medicine sector. The firm is dedicated to developing solutions that enhance the body's natural healing processes for both human and veterinary applications. A central offering is the IStemRewind platform, a patented medical device engineered for the rapid, enzyme-free extraction of adipose-derived stem cells and growth factors.

The IStemRewind system is a fully automated, biological extractor that processes microfragmented adipose tissue (microfat) to isolate stem cells and growth factors. This procedure is completed in under 90 seconds within a sterile, disposable kit, allowing for immediate use directly in a clinical setting and reducing the need for specialized laboratory facilities. The technology avoids enzymatic digestion and in-vitro expansion, which are common in other methods. This mechanical, minimally manipulated approach is designed to preserve cell viability and ensure consistent outcomes.

The company targets the market for osteoarthritis and chronic wound management. Clinical validation has shown the system to be effective in reducing joint pain and restoring joint function. By providing a sterile, ready-to-use biological sample, the device aims to streamline regenerative therapies, lower contamination risks, and reduce costs for clinicians. The business model centers on selling this patented medical device and the accompanying sterile disposable kits to healthcare providers in both human and veterinary medicine.

Keywords: regenerative medicine, medical devices, stem cell extraction, adipose-derived stem cells, osteoarthritis treatment, chronic wound care, tissue regeneration, veterinary medicine, microfragmented adipose tissue, automated cell extraction, enzyme-free extraction, GenLife Biotech, clinical therapies, joint pain management, sterile medical devices, cell therapy, stromal vascular fraction, biologics, medtech